Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 144,163 |
|
|||||
| News | - | ||||||
| Day High | 1.11 | Low High |
|||||
| Day Low | 1.02 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Xilio Therapeutics Inc | XLO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.06 | 5.94% | 1.07 | 18:34:42 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.02 | 1.02 | 1.11 | 1.09 | 1.01 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 706 | 144,163 | US$ 1.08 | US$ 155,169 | - | 0.49 - 3.40 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:33:03 | formt | 113 | US$ 1.07 | USD |
Xilio Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 30.57M | 27.54M | - | 0 | -76.4M | -2.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Xilio Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XLO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.25 | 1.28 | 0.951 | 1.08 | 315,210 | -0.18 | -14.40% |
| 1 Month | 1.32 | 1.63 | 0.951 | 1.45 | 1,797,909 | -0.25 | -18.94% |
| 3 Months | 0.66 | 1.93 | 0.5001 | 1.21 | 1,291,523 | 0.41 | 62.12% |
| 6 Months | 1.90 | 2.8938 | 0.49 | 1.15 | 683,639 | -0.83 | -43.68% |
| 1 Year | 3.22 | 3.40 | 0.49 | 1.18 | 348,575 | -2.15 | -66.77% |
| 3 Years | 15.00 | 27.95 | 0.49 | 2.73 | 187,378 | -13.93 | -92.87% |
| 5 Years | 15.00 | 27.95 | 0.49 | 2.73 | 187,378 | -13.93 | -92.87% |
Xilio Therapeutics Description
| Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index. |
